Bizarre Patents
A self defense weapon formed as a memo pad and which is easily held by a person's fingers, therefore making it possible to provide protection from a mugger and also to quickly and easily write a record or a message without failure of missing or forgetting significant information under a stressful situation.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 8093227 | Monosaccharide compounds and methods therefor A monosaccharide compound of formula I as shown in the specification. Processes for the preparation of the compound of formula I and methods of screening for antibacterial or antibiotic compounds involving the compound of formula I. ... | 01/10/2012 |
| 8034796 | Glucosamine and glucosamine/anti-inflammatory mutual prodrugs, compositions, and methods Mutual prodrugs of glucosamine, and derivatives and analogs of glucosamine and an anti-inflammatory agent, compositions thereof, and methods for, e.g., treating disorders and conditions by administration of the compositions are provided. Topical compositions of gluc... | 10/11/2011 |
| 7947662 | Folates, compositions and uses thereof The present invention relates to folates, compositions and uses thereof; In particular, this invention describes a crystalline or amorphous compound which is a substituted or unsubstituted folate or a reduced folate, or the natural or unnatural isomers thereof, of a... | 05/24/2011 |
| 7943598 | Use of organic glucosamine salts The present invention relates to the use of an organic glucosamine salt selected from glucosamine glucuronate, glucosamine ascorbate, glucosamine malate, glucosamine hydrogen malate, glucosamine citrate, glucosamine hydrogen citrate, and glucosamine dihydrogen citra... | 05/17/2011 |
| 7928090 | External preparation composition An external preparation composition used for preventing or treating symptoms or diseases related to dermatopathy caused by dryness, UV rays and aging such as wrinkles and sags of the skin, pigmentation of the skin, skin roughness and coarse texture and skin diseases... | 04/19/2011 |
| 7893041 | Oligosaccharide compositions and use thereof in the treatment of infection Oligosaccharides and oligosaccharides linked to backbones such as proteins, methods for making such oligosaccharides and methods for using them to treat and/or prevent various disorders are described. ... | 02/22/2011 |
| 7879824 | Methods of preventing or treating diseases and conditions using complex carbohydrates The invention relates to a method of preventing and treating diseases and conditions associated with allergies, autoimmunity, the adhesion cascade, the metastatic cascade or the coronary cascade comprising administering (i) at least one complex carbohydrate as the s... | 02/01/2011 |
| 7855188 | Quarternized amino glucosamine compound for exerting anticancer effect The present invention relates to the quaternized amino glucosamine, it can exert an anticancer effect via induction of apoptosis in a dose and time dependant manner through which an anticancer treatment effect can be increased. ... | 12/21/2010 |
| 7851458 | Cartilage enhancing food supplements and methods of preparing the same A food supplement, either in the form of a snack bar or a beverage, which contains one or more cartilage enhancing supplements is provided. The cartilage supplements include chondroitin, glucosamine, and hyaluronic acid. The food supplement may additionally be forti... | 12/14/2010 |
| 7846914 | Composition for the treatment and prevention of endothelial dysfunction A composition and method for pain relief and the treatment and prevention of endothelial dysfunction the cause of atherosclerosis, cardiovascular disease, hypertension, and stroke in mammals comprising a therapeutically effective amount of anti-inflammatory agents c... | 12/07/2010 |
| 7803787 | Composition and method for treating connective tissue damage by transmucosal administration The present invention provides a composition, and a method of use thereof for treating connective tissue damage in man and in animals, which comprises a therapeutically effective amount of chondroitin sulfate, N-acetyl D-glucosamine, and hyaluronan (hyaluronic acid)... | 09/28/2010 |
| 7776843 | Therapeutic uses of glucan The present invention is directed to methods of using glucan compositions, comprising water insoluble microparticulate glucans, in the treatment of bone injuries. The water insoluble microparticulate glucans used in the compositions comprise branched β-(1.3)(1.6) g... | 08/17/2010 |
| 7776842 | Amino sugar chelates The present invention includes amino sugar chelates and methods for preparing amino sugar chelates of the formula given below, where M is a metal; R2 and R3 are independently selected from H, OH and hydroxyl substituted C1-C8 | 08/17/2010 |
| 7763595 | Method of treatment of skin with external preparation composition An external preparation composition used for preventing or treating symptoms or diseases related to dermatopathy caused by dryness, UV rays and aging such as wrinkles and sags of the skin, pigmentation of the skin, skin roughness and coarse texture and skin diseases... | 07/27/2010 |
| 7704976 | Use of N-acetyl-D-glucosamine for preparing medicines for urogenital tract infection's treatment and prevention The present invention discloses a use of N-acetyl-D-glucosamine in the manufacture of a medicament for treatment of urogenital tract infection. N-acetyl-D-glucosamine exhibits a function of suppressing the transplantation of exotic microorganisms and promoting the r... | 04/27/2010 |
| 7683042 | Stabilized halide-free glucosamine base and method of preparation A stabilized glucosamine base composition comprising a glucosamine base having a purity level of at least 99.0 wt. % and a maximum halide content of about 0.01 wt. % coated with at least one pharmaceutically acceptable polymer comprising a water-soluble, water-immis... | 03/23/2010 |
| 7662803 | Method for treating warm-blooded vertebrates with halide-free glucosamine-acidic drug complexes A method of treating a warm-blood vertebrate. The vertebrate may be a human being or a lower animal. The treatment method involves administering to the vertebrate in need of such treatment a pharmaceutically effective amount of a complex of halide-free glucosamine a... | 02/16/2010 |
| 7662802 | Halide-free glucosamine-acidic drug complexes A complex of glucosamine having a purity of at least about 99 wt. % and a maximum halide content of about 0.01 wt. %, and a therapeutic drug having a pKa of less than 7. Preferably, the complex is stabilized by coating it with at least one pharmaceuticall... | 02/16/2010 |
| 7659260 | Tamponade compositions and methods for retinal repair Described herein are methods of repairing retinal tissue using resorbable tamponade compositions that are heavier than aqueous humor and contain one or more glysosaminoglycans. ... | 02/09/2010 |
| 7612049 | Method of inhibition the growth of algae The inhibition of Chlorophyta growth in water needed to be treated can be accomplished by the addition of about 100 ppm glucosamine. The inhibition of Microcystic aeruginosa and Microcystis flos-aquae growth in water needed to be treated can be accompl... | 11/03/2009 |
| 7504387 | Glycosaminoglycan composition and method for treatment and prevention of interstitial cystitis The invention provides compositions and methods useful for the treatment and/or prevention of interstitial cystitis and/or a related urinary tract condition in man or in animals. Specifically, provided are compositions specially formulated for direct instillation in... | 03/17/2009 |
| 7435812 | Method for preparing a glucosamine compound and compound thus obtained Method for preparing a compound comprising protonated glucosamine and Cl−, Na+ and SO42− ions, in which (a) glucosamine hydrochloride and a stoichiometric excess of sodium sulphate are placed in water, (b) the mixture ... | 10/14/2008 |
| 7429573 | Method for increasing the bone mineral density and bone micro-architecture or connectivity of a mammal using N-acylated glucosamines A method of treating a mammal for a purpose selected from the group consisting of (a) increasing bone mineral density (BMD), (b) treating low BMD, (c) preventing and treatment of low impact fractures, (d) treatment of high impact fractures; (e) treating osteoporosis... | 09/30/2008 |
| 7425573 | Use of annellated pyrrole compounds in the treatment of articular cartilage or subchondral bone degeneration Treating or preventing degeneration or destruction of articular cartilage and/or subchondral bone in the affected joint of a mammal is accomplished by administering a compound of formula (I), wherein the variables have the meanings given in the present description. ... | 09/16/2008 |
| 7416748 | Arthritis phyto-nutraceutical synergistic composition A Phytoceutical composition for the prevention and treatment of arthritis is provided. A specific combination of extracts of plants and nutraceuticals is taught, as well as principles for varying the formulations based on categorizing plants and nutraceuticals into ... | 08/26/2008 |
| 7393937 | N-acetylglucosamine derivatives and use thereof The present invention relates to An N-acetylglucosamine derivative represented by the following formula (1), and a hyaluronic acid production promoting agent containing the same and a skin external preparation containing the same: | 07/01/2008 |
| 7388000 | Halide-free glucosamine phosphate compositions and methods of preparation Glucosamine phosphate having a purity of at least about 99 wt. %, and a maximum halide content of about 0.01 wt. %. Preferably, the glucosamine phosphate is stabilized by coating it with at least one pharmaceutically acceptable polymer comprising a water-soluble, wa... | 06/17/2008 |
| 7388001 | Halide-free glucosamine sulfate compositions and methods of preparation Glucosamine sulfate having a purity of at least about 99 wt. %, and a maximum halide content of about 0.01 wt. %. Preferably, the glucosamine sulfate is stabilized by coating it with at least one pharmaceutically acceptable polymer comprising a water-soluble, water-... | 06/17/2008 |
| H2218 | Glucosamine and method of making glucosamine from microbial biomass Glucosamine suitable for human or animal consumption is disclosed. The glucosamine is derived from microbial biomass containing chitin. Suitable starting materials include substantially uniform microbial fungal sources, such as fungal sources derived from Aspergi... | 06/03/2008 |
| 7364880 | Integration of at least two processes to re-use acid The invention relates to integrating at least two processes that use at least one acid, wherein one process utilizes an ion-exchange purification step. ... | 04/29/2008 |
| 7361644 | Specific antagonist for both E- and P-selectins Compounds and methods are provided for modulating in vitro and in vivo processes mediated by selectin binding. More specifically, selectin modulators and their use are described, wherein the selectin modulators that modulate (e.g., inhibit or enhance) a selectin-med... | 04/22/2008 |
| 7345031 | Pharmaceutical dopamine glycoconjugate compositions and methods of their preparation and use Hydrophilic transportable N-linked glycosyl dopaminergic prodrug compounds according to FORMULA V and methods of their use, wherein, Ring 1 comprises an aryl or heteroaryl ring having 4 to... | 03/18/2008 |
| 7345030 | Use of n-acetyl-d-aminoglycosamine in treatment of organ lesions related to toxicosis of drugs or chemicals The present invention is directed to the use of N-acetyl-D-glucosamine to treat organ lesions caused by toxicants and drugs. The present invention is also directed to a method for treating organ lesions caused by toxicant comprising administering to a patient suffer... | 03/18/2008 |
| 7338942 | Composition and method for maintaining healthy mobile joints and cartilage Compositions and methods for maintaining healthy mobile joints and cartilage in humans and animals are disclosed. The composition comprises glucosamine and chondroitin dispersed in a controlled-release matrix system capable of releasing the glucosamine and chondroit... | 03/04/2008 |
| 7338943 | Hyaluronic acid in soft gel form An orally administered soft gelatin formulation preparation of low molecular weight Hyaluronic Acid (HA) for use as a nutritional supplement to provide the primary benefit of internally causing the softening of the human skin. ... | 03/04/2008 |
| 7335384 | Nutrient compositions for the treatment and prevention of inflammation and disorders associated therewith The present disclosure describes a novel composition for the treatment and/or prevention of neurogenic inflammation. Such composition is also useful in the treatment and/or prevention of disease states and conditions associated with neurogenic inflammation. Such dis... | 02/26/2008 |
| 7332304 | Process and materials for production of glucosamine and N-acetylglucosamine A biosynthetic method for producing glucosamine and N-acetylglucosamine is disclosed. Such a method includes the fermentation of a genetically modified microorganism to produce glucosamine and/or N-acetylglucosamine. Also disclosed are genetically modified microorga... | 02/19/2008 |
| 7323452 | Method for the accelerated in vivo removal of ethanol A method for accelerating the process of removing ethanol from the blood through the use of certain additives that accelerate the metabolic oxidation of ethanol, and others which in addition act as catalysts or “pseudo” enzymes for the oxidation. These additives... | 01/29/2008 |
| 7316989 | Compositions inducing plants disease-resistance and process for producing the same There is provided a plant disease resistance-inducing composition comprising a filamentous fungus-derived glycosphingolipid. There is also provided a method for controlling a plant disease, comprising the step of treating a target plant with a composition comprising... | 01/08/2008 |
| 7317018 | Anti-inflammatory medicament The use of adenosine-5′-triphosphate-2′,3′-dialdehyde (oATP) as a medicament useful for the treatment of inflammatory conditions is disclosed. ... | 01/08/2008 |
